Kava-kava, a psychoactive beverage, induces relaxation, improves social interaction,
promotes sleep and plays an important role in the sociocultural life in the islands
of the South Pacific. On the other hand, standardized extracts of kava-kava roots
are used for the therapy of anxiety, tension and restlessness. Kava pyrones, the major
constituents of kava kava, are generally considered to be responsible for the pharmacological
activity in humans and animals. To obtain more information on the mechanisms by which
kava-kava exerts psychotropic properties we investigated the in vitro effects of kava-kava
extract and pure synthetic kava pyrones on human platelet MAO-B, in comparison to
amitriptyline, imipramine and brofaromine. Kava-kava extract was found to be a reversible
inhibitor of MAO-B in intact platelets (IC50 24 μM) and disrupted platelet homogenates (IC50 1.2 μM). Structural differences of kava pyrones resulted in a different potency of
MAO-B inhibition. The order of potency was desmethoxyyangonin > (±)-methysticin >
yangonin > (±)-dihydromethysticin > (+)- dihydrokavain > (±)-kavain. The two most
potent kava pyrones, desmethoxyyangonin and (±)-methysticin displayed a competetive
inhibition pattern with mean Ki 0.28 μM and 1.14 ?M respectively. The inhibition of
MAO-B by kava pyrone-enriched extracts might be an important mechanism for their psychotropic
activity.